Richard Sherman M.D. is Director at ICU MEDICAL INC/DE (ICUI). They have made 6 open-market trades across 1 company since 2011, most recently 2017-05-16.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ICUI | 69,942 | $10.9M |
Shares reported on the most recent Form 4, priced at the 2017-05-16 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICUI | SELL | 2017-03-14 | 2017-03-14 | $152.20 | $457K | +1.6% | -4.0% | +9.1% |
| ICUI | SELL | 2016-10-06 | 2016-10-07 | $140.60 | $211K | -5.1% | -5.5% | -2.5% |
| ICUI | SELL | 2016-09-19 | 2016-09-19 | $122.51 | $368K | +2.0% | +17.1% | +20.7% |
| ICUI | SELL · 10b5-1 | 2015-08-03 | 2015-08-03 | $100.00 | $150K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL · 10b5-1 | 2015-04-01 | 2015-04-01 | $95.00 | $143K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL · 10b5-1 | 2015-01-13 | 2015-01-14 | $85.00 | $723K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL · 10b5-1 | 2014-12-22 | 2014-12-22 | $83.06 | $311K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL · 10b5-1 | 2014-10-20 | 2014-10-21 | $70.00 | $180K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL · 10b5-1 | 2014-10-17 | 2014-10-17 | $70.00 | $83K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL | 2013-12-18 | 2013-12-18 | $65.00 | $244K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL | 2013-12-09 | 2013-12-09 | $65.42 | $101K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL · 10b5-1 | 2012-03-16 | 2012-03-19 | $48.00 | $1.3M | -10.5% | -5.2% | -5.2% |
| ICUI | SELL · 10b5-1 | 2012-01-27 | 2012-01-27 | $46.00 | $86K | -10.5% | -5.2% | -5.2% |
| ICUI | SELL | 2011-06-06 | 2011-06-07 | $41.27 | $206K | -10.5% | -5.2% | -5.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.